e.g. mhealth
Search Results (1 to 4 of 4 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 1 JMIR Formative Research
- 1 JMIR Public Health and Surveillance
- 1 JMIR mHealth and uHealth
- 1 Journal of Medical Internet Research
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Research Protocols
- 0 JMIR Human Factors
- 0 JMIR Medical Informatics
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
The studies covered a range of diseases, including Ebola, tuberculosis, COVID-19, HIV, and multiple diseases in humans and animals. In total, 74% (14/19) of the included studies were about technologies used for contact tracing of Ebola and tuberculosis. Ebola had the most studies with 42% (8/19), whereas tuberculosis had 32% (6/19). One other technology was used for both tuberculosis and COVID-19.
JMIR Mhealth Uhealth 2024;12:e53211
Download Citation: END BibTex RIS
This study retrospectively uses large public data sets, such as Google Trends and Reddit, to estimate the level of public interest in 6 non-COVID epidemic diseases (chikungunya, Ebola, H1 N1 influenza, Middle Eastern respiratory syndrome [MERS], severe acute respiratory syndrome [SARS], and Zika virus) from 2018 through the end of 2020.
JMIR Form Res 2023;7:e44603
Download Citation: END BibTex RIS
As part of an ongoing Ebola vaccine clinical trial (EBOVAC3, study protocol number VAC52150 EBL2007, clinicaltrials.gov identifier NCT04186000) [13], we assessed acceptability, accuracy, and feasibility of iris scan technology as a biometric identification method within a population of health care provider participants in a remote setting.
J Med Internet Res 2021;23(8):e28573
Download Citation: END BibTex RIS
The 2014-2016 Ebola epidemic in West Africa was an unprecedented public health emergency afflicting more than 28,000 people and claiming more than 11,000 lives [1]. The Centers for Disease Control and Prevention (CDC) extended international efforts to control and prevent disease spread in West Africa and implemented domestic measures to prevent the introduction and transmission of Ebola in the United States [2,3].
JMIR Public Health Surveill 2017;3(4):e89
Download Citation: END BibTex RIS